News & Events

June 2016

June 22, 2016 Cellular Dynamics and the National Eye Institute Establish a Cooperative Research and Development Agreement (CRADA) to Advance Cell Transplantation Therapy for the Treatment of Retinal Degenerative Disease using iPSC-Derived CellsDownload PDF

MADISON, WIS., June 22, 2016 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI), a division of the National Institutes of Health (NIH), to conduct research to advance a cell transplantation therapy for the treatment of retinal degenerative disease using retinal pigment epithelium derived from induced pluripotent stem cells (iPSC-RPE). The collaboration includes the joint development of an optimized biocompatible biodegradable scaffold that is likely to be acritical component for a potential future therapy.

May 2016

May 25, 2016 Michael J. Fox Foundation Supports Two Engineered Stem Cell Research Projects for Parkinson’s Therapeutic Development and Disease InvestigationDownload PDF

NEW YORK (May 25, 2016) — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced
funding for two projects leveraging the promise of engineered stem cells to speed new therapies and
deeper understanding of Parkinson’s disease.

May 25, 2016 Cellular Dynamics Announces Partnership with The Michael J. Fox Foundation for Parkinson’s Research to Provide Resources for Developing New TherapiesDownload PDF

MADISON, WIS., May 25, 2016Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced an agreement with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to derive induced pluripotent stem cells (iPSCs) from 85 people in the MJFF-sponsored Parkinson’s Progression Markers Initiative (PPMI). The collaborators will provide the cells to the scientific community in concert with rich available clinical and imaging data on these study volunteers in service to their shared goal to provide resources to accelerate the development of new therapies.

April 2016

April 4, 2016 Cell Therapy Company Licenses IU School of Medicine Technology that Creates Blood Vessels

INDIANAPOLIS — Indiana University Research and Technology Corp., which protects intellectual property developed in the Indiana University campus system, has licensed technology that creates human blood vessels to Cellular Dynamics International, a Fujifilm company based in Madison, Wisconsin.

November 2015

November 10, 2015 Cellular Dynamics Announces Collaboration with RocheDownload PDF

Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced an agreement with Roche to supply CDI’s induced pluripotent stem cell (iPSC)-derived iCell products to contribute to the identification of novel drug candidates at the early stages of drug discovery.

September 2015

September 1, 2015 Cellular Dynamics Announces Launch of World’s Largest Public Stem Cell Bank and the Availability of the First 300 iPSC LinesDownload PDF

Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced the launch of the world’s largest publicly available stem cell bank, the California Institute for Regenerative Medicine (CIRM) hPSC Repository, and the availability of the first 300 induced pluripotent stem cell (iPSC) lines in September. These high quality, disease-specific iPSC resources are now accessible to academic and industry researchers for disease modeling, target discovery and drug discovery.

August 2015

August 20, 2015 SeouLin Bioscience to Distribute Cellular Dynamics’ Products in Korea

MADISON, WIS., August 20, 2015 — Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced an exclusive agreement with SeouLin Bioscience Co., Ltd., for the distribution of CDI’s products in the Republic of Korea.

August 13, 2015 Cellular Dynamics to Host iForum™ Meetings Focused on Human iPSC Research and Applications

MADISON, WIS., August 13, 2015 – Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, will host the annual iForum™ 2015 Meeting: US on September 14-16 in Chicago, IL. With the rapidly growing interest in and use of iPSCs over recent years in drug discovery and cell therapy applications, iForum 2015 Meetings represent a natural evolution of the former CDI User Group Meetings. The iForum 2015 Meeting: Europe is slated to be held in Hamburg, Germany, on October 19.

May 2015

May 19, 2015 Cellular Dynamics Wins Gold for Innovation in Research and Education at 2015 International Edison Awards CeremonyDownload PDF

Cellular Dynamics International, Inc. (CDI) announced that its MyCell® Disease & Diversity Products received the 2015 Gold Edison Award in the Science/Medical/Dental Research and Education category at a gala in New York City on April 23, 2015.

March 2015

March 30, 2015 Fujifilm Holdings to Acquire Cellular Dynamics International, Inc.Download PDF

OKYO and MADISON, Wis., March 30, 2015 /PRNewswire/ — FUJIFILM Holdings Corporation (President: Shigehiro Nakajima,) (TSE: 4901) (“Fujifilm”) and Cellular Dynamics International, Inc. (CEO: Robert J. Palay,) (NASDAQ: ICEL) (“CDI”), a leading developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced that the two companies have entered into a definitive agreement whereby Fujifilm will acquire CDI via an all-cash tender offer to be followed by a second step merger.